Author:
Matsubara Shuya,Saito Akira,Tokuyama Naoto,Muraoka Ryu,Hashimoto Takeshi,Satake Naoya,Nagao Toshitaka,Kuroda Masahiko,Ohno Yoshio
Abstract
AbstractThe recurrence of non-metastatic renal cell carcinoma (RCC) may occur early or late after surgery. This study aimed to develop a recurrence prediction machine learning model based on quantitative nuclear morphologic features of clear cell RCC (ccRCC). We investigated 131 ccRCC patients who underwent nephrectomy (T1-3N0M0). Forty had recurrence within 5 years and 22 between 5 and 10 years; thirty-seven were recurrence-free during 5–10 years and 32 were for more than 10 years. We extracted nuclear features from regions of interest (ROIs) using a digital pathology technique and used them to train 5- and 10-year Support Vector Machine models for recurrence prediction. The models predicted recurrence at 5/10 years after surgery with accuracies of 86.4%/74.1% for each ROI and 100%/100% for each case, respectively. By combining the two models, the accuracy of the recurrence prediction within 5 years was 100%. However, recurrence between 5 and 10 years was correctly predicted for only 5 of the 12 test cases. The machine learning models showed good accuracy for recurrence prediction within 5 years after surgery and may be useful for the design of follow-up protocols and patient selection for adjuvant therapy.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Egger, S. E. et al. Renal cell carcinoma recurrence after nephrectomy for localized disease: Predicting from time of recurrence. J. Clin. Oncol. 24, 3101–3106 (2006).
2. Richards, K. A. & Abel, E. J. Surveillance following surgery for nonmetastatic renal cell carcinoma. Curr. Opin. Urol. 26, 432–438 (2016).
3. Campbell, S. C. et al. Renal mass and localized renal cancer: Evaluation, management, and follow-up: AUA guideline. J. Urol. 206, 209–218 (2021).
4. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Kidney Cancer, version 2. https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf, (2023).
5. Ljungberg, B. et al. European Association of Urology guidelines on renal cell carcinoma: the 2022 update. Eur. Urol. S0302 2838, 01676–01671 (2022). Online ahead of print.